Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Computers in Biology and Medicine|March 1, 1995
Biomechanics for preoperative planning and surgical simulations in orthopaedicsR V O'Toole, B Jaramaz, A M DiGioia, et al.
Gynecologic Oncology|August 1, 1995
Splenectomy as part of cytoreductive surgery for ovarian carcinomaJ L Nicklin, L J Copeland, R V O'Toole, et al.
Investigational New Drugs|May 1, 1991
Esorubicin in advanced endometrial cancer: an ineffective and potentially toxic therapy. A Southwest Oncology Group studyJ B Green, S Green, R V O'Toole, et al.
Acta Medica Portuguesa|April 27, 2001
[Preoperative applications of cortical mapping with functional magnetic resonance]I Cravo, T Palma, C Conceição, et al.
American Journal of Clinical Oncology|April 1, 1992
A phase II evaluation of esorubicin in ovarian cancer. A Southwest Oncology Group studyD S Alberts, N Mason-Liddil, D Stock-Novack, et al.
American Journal of Clinical Oncology|April 1, 1988
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group StudyD D Von Hoff, R Kronmal, R V O'Toole, et al.
Revista Medica De Chile|May 1, 1989
[Sheehan syndrome and spontaneous pregnancy: report of 2 cases]E López-Caffarena, A Jadresic, C Crisosto, et al.
Gynecologic Oncology|June 1, 1987
Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group StudyE A Surwit, D S Alberts, R V O'Toole, et al.
Acta Medica Portuguesa|April 27, 2001
[Hypertrophic olivary degeneration. Semiology with magnetic resonance]C Conceição, T Palma, I Cravo, et al.
Gynecologic Oncology|September 1, 1987
Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group StudyE A Surwit, D S Alberts, R V O'Toole, et al.
Pageof 9